A Long Term Safety Extension Study (CHS-0214-05)
NCT02486939
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
359
Enrollment
INDUSTRY
Sponsor class
Conditions
Rheumatoid Arthritis
Plaque Psoriasis
Interventions
DRUG:
CHS-0214
Sponsor
Coherus Oncology, Inc.
Collaborators
[object Object]
[object Object]